- Stantec’s adjusted earnings per share (EPS) for the fourth quarter were C$1.11, surpassing last year’s C$0.82 and beating the estimated C$0.99.
- The company’s net revenue reached C$1.48 billion, marking a 19% increase from the previous year and exceeding the projected C$1.43 billion.
- Adjusted net income rose by 38% year-over-year to C$126.2 million, outperforming the expected C$113.4 million.
- Stantec reported a project margin of C$813.4 million, up 21% from last year, and higher than the estimate of C$783.6 million.
- Adjusted EBITDA was C$246.5 million, a 27% increase from the prior year, surpassing the forecasted C$240.5 million.
- Investment analysis indicates 9 buy recommendations, 2 hold recommendations, and no sell recommendations for Stantec’s stock.
A look at Stantec Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Stantec Inc. is an engineering and architectural firm with a focus on providing various professional services to clients in North America and across the globe. The company’s Smartkarma Smart Scores highlight its strengths and weaknesses in different areas. While Stantec scores moderately across Value, Dividend, and Resilience, its Growth and Momentum scores are more impressive, indicating potential long-term positive outcomes.
The Smartkarma Smart Scores suggest that Stantec Inc. may have strong growth and momentum prospects in the long run, despite facing challenges in other areas. With a solid focus on expanding its business and increasing market momentum, Stantec could be well-positioned for future success and sustained growth.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
